Entheon Biomedical Corp.
ENBIX
CNSX
| 05/31/2026 | 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 213.90K | 185.10K | 214.70K | 229.20K | 241.90K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 213.90K | 185.10K | 214.70K | 229.20K | 241.90K |
| Operating Income | -213.90K | -185.10K | -214.70K | -229.20K | -241.90K |
| Income Before Tax | 31.10K | -201.30K | -229.90K | -244.20K | -257.10K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 0.03 | -0.20 | -0.23 | -0.24 | -0.26 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 31.10K | -201.30K | -229.90K | -244.20K | -257.10K |
| EBIT | -213.90K | -185.10K | -214.70K | -229.20K | -241.90K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 0.00 | -0.01 | -0.02 | -0.02 | -0.02 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 |
| EPS Diluted | 0.00 | -0.01 | -0.02 | -0.02 | -0.02 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 |
| Average Basic Shares Outstanding | 62.18M | 62.18M | 53.60M | 48.59M | 43.59M |
| Average Diluted Shares Outstanding | 62.18M | 62.18M | 53.60M | 48.59M | 43.59M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |